Mahmood Kassir, Allen Jude, Varley Rebecca, Vrijens Bernard, Huuskes Brooke M, Woywodt Alexander
Department of Renal Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
Specialist Pharmacist, Northern Care Alliance, Salford, UK.
Clin Kidney J. 2025 May 23;18(6):sfaf164. doi: 10.1093/ckj/sfaf164. eCollection 2025 Jun.
Non-adherence is an issue in all chronic health conditions and the World Health Organization estimates that up to 50% of patients do not take all of their medications. The situation in kidney transplant patients is probably better, as these patients are preselected for good adherence and proactive behaviour. Nonetheless, non-adherence remains a common, significant and likely underdiagnosed problem in transplant nephrology. Not taking immunosuppressive medication as directed is strongly correlated with late acute rejection, which is often severe, leading to progressive loss of transplant function and poor outcomes overall. It is important to acknowledge that non-adherence is multifactorial and that interventions work best if clinicians understand risk factors and the causes of non-adherence in their patients. Reflex labelling of patients as non-adherent in documentation and clinic letters is unlikely to be helpful but good documentation is also important. It is also important to be aware of the phases of adherence and to have some knowledge of how to measure non-adherence. Dose simplification may help in some patients and technology can be employed to improve adherence, particularly in younger and information technology-literate patients. Peer support and patient information are also important. Individual assessment is important in patients who have lost a previous transplant due to non-adherence. We also emphasize the importance of a multidisciplinary approach and the relative paucity of robust data in this area. Based on the limited evidence and our individual and departmental experience, our 10 tips aim to provide clinicians with a toolbox of evidence-based interventions to address this important issue in daily clinical practice. We also provide a list of suggestions for institutions to address this important issue at departmental and institutional levels and suggest future research.
在所有慢性健康状况中,不依从都是一个问题,世界卫生组织估计,高达50%的患者未按医嘱服用所有药物。肾移植患者的情况可能较好,因为这些患者是经过预先筛选的,具有良好的依从性和积极主动的行为。尽管如此,不依从在移植肾病学中仍然是一个常见、重要且可能未被充分诊断的问题。不按医嘱服用免疫抑制药物与晚期急性排斥反应密切相关,晚期急性排斥反应通常很严重,会导致移植功能逐渐丧失和总体预后不良。必须认识到,不依从是多因素的,如果临床医生了解患者不依从的风险因素和原因,干预措施的效果最佳。在病历记录和临床信函中将患者简单地标记为不依从不太可能有帮助,但良好的记录也很重要。了解依从性的各个阶段并掌握一些测量不依从性的方法也很重要。剂量简化可能对一些患者有帮助,还可以利用技术来提高依从性,特别是在年轻且熟悉信息技术的患者中。同伴支持和患者信息也很重要。对于因不依从而失去先前移植的患者,个体评估很重要。我们还强调多学科方法的重要性以及该领域可靠数据相对匮乏的情况。基于有限的证据以及我们个人和科室的经验,我们的10条建议旨在为临床医生提供一个基于证据的干预措施工具箱,以在日常临床实践中解决这一重要问题。我们还为机构提供了一系列建议,以在科室和机构层面解决这一重要问题,并提出未来的研究方向。